Sign in
4

Changes in Ownership

GT Biopharma, Inc. Filed Acc 0001641172-25-026892

Options or other derivatives

  • Director acquired 31,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kramer Hilary · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-04 Grant or award : show line 1 in the form Option to purchase Common Stock +31,250 31,250 D
Loading xslF345X05/ownership.xml…